BZFD vs ABEO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABEO Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abeona Therapeutics Inc. Common Stock (ABEO) driven by superior Valuation, Momentum & Technical, Options & Structure while BZFD counters with relative strength in Growth & Margin. Fundamentally, BZFD trades at N/M Forward P/E with -17.7% operating margin (-43.8% YoY revenue) versus ABEO at 18.7x Forward P/E and -186.1% operating margin (+2745.0% YoY). In options structure, BZFD sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro) against ABEO sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BZFD Revenue | ABEO Revenue | BZFD Op. Margin | ABEO Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $0M | N/A | -1940.2% | ABEO |
| FY2019 | $320M | N/A | -12.7% | N/A | BZFD |
| FY2020 | $320M | $10M | 3.8% | -814.2% | BZFD |
| FY2021 | $380M | $0M | -6.2% | -2994.5% | BZFD |
| FY2022 | $330M | $0M | -35.2% | -3600.8% | BZFD |
| FY2023 | $230M | $0M | -19.5% | -1346.7% | BZFD |
| FY2024 | $190M | N/A | -12.4% | N/A | BZFD |
| FY2025 | $190M | $10M | -25.8% | -1536.9% | BZFD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BZFD | ABEO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $38.1M | $167.4M | Larger Scale | ABEO |
| Trailing P/E Ratio Valuation | N/M | 18.7x | Lower Multiple | ABEO |
| Forward P/E Ratio Valuation | N/M | 18.7x | Lower Multiple | ABEO |
| Revenue Growth (YoY) Growth | -43.8% | +2745.0% | Higher Growth | ABEO |
| Operating Margin (TTM) Profitability | -17.7% | -186.1% | Higher Margin | BZFD |
| Net Profit Margin Profitability | -48.0% | -160.3% | Higher Margin | BZFD |
| Return on Equity (ROE) Capital Efficiency | -123.0% | -42.1% | Higher ROE | ABEO |
| 52-Week Range Position Momentum | 2% ($0โ$2) | 6% ($2โ$8) | Stronger Trend | ABEO |
| Beta / 30D Volatility Risk Regime | 2.52ฮฒ ยท 192% Vol | 0.60ฮฒ ยท 149% Vol | Lower Realized Risk | ABEO |
| Unified Institutional Score Composite Signal | 51.3 / 100 (HOLD) | 49.9 / 100 (HOLD) | Higher Composite | BZFD |